Editorial Board

Keep Politics Out of Drug Approval

Congress wants to reform the FDA’s process. Be careful with that.
Updated on

Be careful.

Photographer: Kiyoshi Ota/Bloomberg

Congress has voted to change the way new prescription drugs are approved, in a way that could endanger patients. The deal now under consideration contains a sweetener for lawmakers who might be wary of such a change (Democrats, that is): substantially increased funding for medical research. It’s very effective politics, but not necessarily good policy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.